North America Pharmaceutical Blister Packaging Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 10.06 Billion |
| Market Size (2029) | USD 13.23 Billion |
| CAGR (2024 - 2029) | 5.62 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Pharmaceutical Blister Packaging Market Analysis
The North America Pharmaceutical Blister Packaging Market size is estimated at USD 10.06 billion in 2024, and is expected to reach USD 13.23 billion by 2029, growing at a CAGR of 5.62% during the forecast period (2024-2029).
The growing importance of modern packaging in the pharmaceutical industry has led brands to influence the potential of distinctive packaging design to stand out and increase profitability.
- Blister packaging is witnessing growth in North America. The increase in over-the-counter drugs has also provided an impetus to the market. Growing pressure on pharmaceutical companies to manufacture medicines that are different in packaging is hard to replicate and are made available for patients due to disease growth. Stringent government regulations against counterfeit drugs are among the significant factors propelling the market.
- Blister packaging provides an efficient method of anti-counterfeit systems, like banknote authentication systems. The use of innovative technologies in blisters, such as RFID, deployed with a seal applied outside the packaging, is growing due to the potential to offer individual security throughout supply chains.
- New product innovations are being designed to deliver more choices. For instance, in June 2023, Pharmaworks and Serpa, brands of ProMach Inc., introduced the new, fully integrated blister transport system (BTS) at Pack Expo Las Vegas, which is ideal for pharmaceutical, medical device, biotech, nutraceutical, and other products. The new BTS transfers blisters from a blister machine and collates them to feed a carton, handling a range of blister format sizes and collating up to ten blisters per bucket. The new BTS will help address the challenge of the packaging line, which is the transfer point. This will reduce the need for separate systems for blister packaging.
- The blister packaging in the pharmaceuticals includes tablets and sachet packing of dispersible powders. Flexible packaging materials such as plastic, paper, and more are used for blister packaging. Any change in the region's regulations and standards for packaging would impact the market growth over the forecast period.
- Moreover, the COVID-19 pandemic created a need for good-quality pharmaceutical packaging as it raised concerns about the virus' ability to survive on packaging surfaces. Further, according to the American Hospital Association, an increasing number of Americans are handling chronic health diseases that are ongoing and typically not curable. A calculated 133 million Americans, nearly half the residents, have at least one chronic illness, such as hypertension, heart disease, and arthritis. Heart disease affects more than 79 million Americans and is responsible for 40% of all deaths.
North America Pharmaceutical Blister Packaging Market Trends
Plastic Blister Packaging to Witness Growth in the Region
- The fundamental characteristic of blister packages is the capability of sealing individual tablets or capsules within dedicated cavities for each dose. It is typically made of thermo-formed plastics or cold-form processes to protect the drug from contaminants such as moisture, oxygen, and even light by utilizing the plastic film barrier.
- Track and trace solutions integrated with blister packaging applications drive the market as they can trace an individual product dose back to a single blister cavity. They also give the manufacturer, pharmacists, and patients a mechanism to verify and confirm if their product is authentic.
- The steady growth of the pharmaceutical industry is pushing the demand-supply curve upward, and various guidelines for pharmaceutical packaging are also catalyzing blister packaging manufacturers' change. For instance, per FDA guidelines, pharmaceutical packaging must have features that avert mix-ups and cross-contamination and specify processes for examining packaging for suitability before packaging operations, a measure met by blister packaging.
- The aging population is increasing rapidly and is expected to continue during the forecast period, leading to high demand for pharmaceuticals and market growth. The rising incidence of chronic diseases such as cancer and infectious diseases and the aging population needing advanced and patient-friendly packaging is also expected to drive the blister packaging market during the forecast period. Blister packaging is a convenient and easy-to-use packaging format for solid oral medicines. This is especially accurate for older patients who often have difficulty opening medicine bottles.
- According to ChildStats and the US Census Bureau, the share of the old age population in 2022 was 17.3%, increasing from 16.9% in 2021. The share is anticipated to increase to 20.6% by 2030. The rise in the country's senior population is expected to further drive the demand for elder care, leveraging the demand for pharmaceutical blister packaging during the forecast period.
The United States to be the Fastest-growing Country
- Blister packaging is noticing growth in the country. The high safety offered by blister packaging solutions raises the demand for these solutions. An increase in over-the-counter drugs is also a driving factor in the market.
- In April 2024, Pharmaworks, a Promach product brand, debuted its new capability to handle recyclable, mono-material packaging films on its blister machines at Interphex. The company will provide upgrades for installed Pharmaworks blister machines in the field. It can rebuild blister machines from other suppliers to handle these new sustainable films. As North America's blister machine manufacturer, the company is helping improve sustainability by ensuring its equipment is compatible with the new mono-base and mono-lid materials.
- The market is witnessing growth with benefits offered by blister packaging, including helping patients efficiently manage their medication schedules. The individual compartments enable verification of whether a dose has been taken or missed, thereby reducing the possibility of medication errors. Blister pack packaging finds usage for medications requiring precise dosing, like birth control pills, and over-the-counter products, such as vitamins and supplements. Additionally, it is frequently employed in hospitals to dispense medications to patients.
- In March 2023, Adare Pharma Solutions, a contract development and manufacturing organization, announced it had chosen Vantage Solutions to lead a significant upgrade of its pharmaceutical packaging capabilities. Vantage's upgrades will allow Adare to serve its clients’ needs at its FDA-registered packaging facility in Philadelphia, Pennsylvania. The site delivers a full range of solid-dose contract packaging services at clinical and commercial scales, including blister packs and other products.
- According to Lakeside Pharmacy, blister packs provide a safe and convenient way to take the prescribed medication. Each day, any medication patients need is separated from the rest into small packs, making it a suitable choice. According to the Drug Channels Institute, the leading pharmacies in the United States in 2023 based on prescription revenue was topped by CVS Health Corporation, which was USD 159.4 billion, and Walgreens Boots Alliance took the second position with USD 91.1 billion in the same year.
North America Pharmaceutical Blister Packaging Industry Overview
The pharmaceutical blister packaging market is fragmented, with various major players such as Amcor Limited, Constantia Flexibles, Westrock Company, Klockner Pentaplast Group, and Sonoco Products Company operating in the industry. The players are focused on expanding their business in the region through acquisitions, collaborations, mergers, and more.
- January 2024: TekniPlex Healthcare joined forces with Alpek Polyester to introduce pharmaceutical-grade polyethylene terephthalate (PET) blister film, including 30% post-consumer recycled (PCR) monomers. This innovative collaboration aims to offer pharmaceutical companies a fully recyclable blister pack option that aligns with strict quality standards for product protection and consumer safety while contributing to environmental sustainability.
- July 2023: Constantia Flexibles unveiled its latest pharmaceutical packaging solution, the cold-form foil REGULA CIRC. This cutting-edge technology sets a unique standard for sustainability in blister packaging, delivering many benefits for consumers and the planet. With circularity at its core, REGULA CIRC is developed to comply with forthcoming regulations and legislation, providing a complete barrier solution that fulfills the highest sustainable packaging standards.
North America Pharmaceutical Blister Packaging Market Leaders
-
Amcor Limited
-
Constantia Flexibles
-
WestRock Company
-
Klockner Pentaplast Group
-
Sonoco Products Company
*Disclaimer: Major Players sorted in no particular order
North America Pharmaceutical Blister Packaging Market News
- February 2024: ViiV Healthcare, a global company specializing in human immunodeficiency virus (HIV), announced the launch of Dovato in a new blister pack format in the United States. Dovato is a once-daily, single-pill, two-drug prescription regimen to treat HIV-1 in adults. Dovato’s blister pack seeks to deliver a discreet and convenient medication management option for people with HIV.
- November 2023: Schreiner MediPharm launched a variety of smart blister packs for clinical trials by partnering with packaging specialist Keystone Folding Box Co., the specialist for the pharmaceutical industry, which is expanding its portfolio with a specifically child-resistant and senior-friendly solution. Schreiner MediPharm has developed an extension for the proven Key-Pak wallet for oral solid dose medication from a US-based Keystone Folding Box Company, and the Smart Blister Wallet based on Key-Pak is child-resistant and senior-friendly.
North America Pharmaceutical Blister Packaging Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumption and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
- 4.1 Market Overview
-
4.2 Industry Attractiveness - Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Threat of Substitutes
- 4.2.5 Intensity of Competitive Rivalry
- 4.3 Industry Value Chain Analysis
5. MARKET DYNAMICS
-
5.1 Market Drivers
- 5.1.1 Growing Geriatric Population and Prevalence of Diseases
- 5.1.2 New Product Innovations with Sustainable Materials
-
5.2 Market Restraints
- 5.2.1 Dynamic Nature of Regulations in the Region
6. MARKET SEGMENTATION
-
6.1 By Material
- 6.1.1 Plastic
- 6.1.2 Paper
- 6.1.3 Aluminum
-
6.2 By Technology
- 6.2.1 Cold Forming
- 6.2.2 Thermoforming
-
6.3 By Country
- 6.3.1 United States
- 6.3.2 Canada
7. COMPETITIVE LANDSCAPE
-
7.1 Company Profiles*
- 7.1.1 Amcor Limited
- 7.1.2 Constantia Flexibles
- 7.1.3 WestRock Company
- 7.1.4 Klockner Pentaplast Group
- 7.1.5 Sonoco Products Company
- 7.1.6 Honeywell International Inc.
- 7.1.7 DuPont de Numerous Inc.
- 7.1.8 Aphena Pharma Solutions
- 7.1.9 The Dow Chemical Company
- 7.1.10 Tekni-Plex Inc.
8. INVESTMENT ANALYSIS
9. MARKET FUTURE OUTLOOK
** Subject To AvailablityNorth America Pharmaceutical Blister Packaging Industry Segmentation
With growing consumer needs and regulatory requirements evolving, pharmaceutical companies depend more on their packaging to protect and promote their products. Therefore, blister packs remain the pharma industry's preferred and fastest-growing packaging options.
The North American pharmaceutical blister packaging market is segmented by material (plastic, paper, aluminum), technology (cold forming, thermoforming), and country (United States, Canada). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.
| By Material | Plastic |
| Paper | |
| Aluminum | |
| By Technology | Cold Forming |
| Thermoforming | |
| By Country | United States |
| Canada |
North America Pharmaceutical Blister Packaging Market Research FAQs
How big is the North America Pharmaceutical Blister Packaging Market?
The North America Pharmaceutical Blister Packaging Market size is expected to reach USD 10.06 billion in 2024 and grow at a CAGR of 5.62% to reach USD 13.23 billion by 2029.
What is the current North America Pharmaceutical Blister Packaging Market size?
In 2024, the North America Pharmaceutical Blister Packaging Market size is expected to reach USD 10.06 billion.
Who are the key players in North America Pharmaceutical Blister Packaging Market?
Amcor Limited, Constantia Flexibles, WestRock Company, Klockner Pentaplast Group and Sonoco Products Company are the major companies operating in the North America Pharmaceutical Blister Packaging Market.
What years does this North America Pharmaceutical Blister Packaging Market cover, and what was the market size in 2023?
In 2023, the North America Pharmaceutical Blister Packaging Market size was estimated at USD 9.49 billion. The report covers the North America Pharmaceutical Blister Packaging Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Pharmaceutical Blister Packaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Pharmaceutical Blister Packaging Industry Report
Statistics for the 2024 North America Pharmaceutical Blister Packaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Pharmaceutical Blister Packaging analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
